-
Je něco špatně v tomto záznamu ?
Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides
T. Gonec, I. Zadrazilova, E. Nevin, T. Kauerova, M. Pesko, J. Kos, M. Oravec, P. Kollar, A. Coffey, J. O'Mahony, A. Cizek, K. Kralova, J. Jampilek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- ampicilin farmakologie MeSH
- anilidy chemická syntéza farmakologie MeSH
- antibakteriální látky chemická syntéza farmakologie MeSH
- buněčné linie MeSH
- chloroplasty účinky léků fyziologie MeSH
- fotosyntéza účinky léků fyziologie MeSH
- lidé MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků růst a vývoj MeSH
- mikrobiální testy citlivosti MeSH
- mikrobiální viabilita účinky léků MeSH
- monocyty cytologie účinky léků MeSH
- Mycobacterium avium subsp. paratuberculosis účinky léků růst a vývoj MeSH
- Mycobacterium tuberculosis účinky léků růst a vývoj MeSH
- naftaleny chemická syntéza farmakologie MeSH
- rifampin farmakologie MeSH
- Spinacia oleracea účinky léků fyziologie MeSH
- transport elektronů účinky léků fyziologie MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A series of fifteen new N-alkoxyphenylanilides of 3-hydroxynaphthalene-2-carboxylic acid was prepared and characterized. Primary in vitro screening of the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra and M. avium subsp. paratuberculosis. Some of the tested compounds showed antibacterial and antimycobacterial activity against the tested strains comparable with or higher than that of the standards ampicillin or rifampicin. 3-Hydroxy-N-(2-propoxyphenyl)naphthalene-2-carboxamide and N-[2-(but-2-yloxy)-phenyl]-3-hydroxynaphthalene-2-carboxamide had MIC = 12 µM against all methicillin-resistant S. aureus strains; thus their activity is 4-fold higher than that of ampicillin. The second mentioned compound as well as 3-hydroxy-N-[3-(prop-2-yloxy)phenyl]-naphthalene-2-carboxamide had MICs = 23 µM and 24 µM against M. tuberculosis respectively. N-[2-(But-2-yloxy)phenyl]-3-hydroxynaphthalene-2-carboxamide demonstrated higher activity against M. avium subsp. paratuberculosis than rifampicin. Screening of the cytotoxicity of the most effective antimycobacterial compounds was performed using THP-1 cells, and no significant lethal effect was observed for the most potent compounds. The compounds were additionally tested for their activity related to inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. N-(3-Ethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide (IC50 = 4.5 µM) was the most active PET inhibitor. The structure-activity relationships are discussed.
Department of Biological Sciences Cork Institute of Technology Bishopstown Cork Ireland
Global Change Research Centre AS CR Belidla 986 4a 60300 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010145
- 003
- CZ-PrNML
- 005
- 20160415122509.0
- 007
- ta
- 008
- 160408s2015 sz f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.3390/molecules20069767 $2 doi
- 024 7_
- $a 10.3390/molecules20069767 $2 doi
- 035 __
- $a (PubMed)26023938
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gonec, Tomas $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. t.gonec@seznam.cz.
- 245 10
- $a Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides / $c T. Gonec, I. Zadrazilova, E. Nevin, T. Kauerova, M. Pesko, J. Kos, M. Oravec, P. Kollar, A. Coffey, J. O'Mahony, A. Cizek, K. Kralova, J. Jampilek,
- 520 9_
- $a A series of fifteen new N-alkoxyphenylanilides of 3-hydroxynaphthalene-2-carboxylic acid was prepared and characterized. Primary in vitro screening of the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra and M. avium subsp. paratuberculosis. Some of the tested compounds showed antibacterial and antimycobacterial activity against the tested strains comparable with or higher than that of the standards ampicillin or rifampicin. 3-Hydroxy-N-(2-propoxyphenyl)naphthalene-2-carboxamide and N-[2-(but-2-yloxy)-phenyl]-3-hydroxynaphthalene-2-carboxamide had MIC = 12 µM against all methicillin-resistant S. aureus strains; thus their activity is 4-fold higher than that of ampicillin. The second mentioned compound as well as 3-hydroxy-N-[3-(prop-2-yloxy)phenyl]-naphthalene-2-carboxamide had MICs = 23 µM and 24 µM against M. tuberculosis respectively. N-[2-(But-2-yloxy)phenyl]-3-hydroxynaphthalene-2-carboxamide demonstrated higher activity against M. avium subsp. paratuberculosis than rifampicin. Screening of the cytotoxicity of the most effective antimycobacterial compounds was performed using THP-1 cells, and no significant lethal effect was observed for the most potent compounds. The compounds were additionally tested for their activity related to inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. N-(3-Ethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide (IC50 = 4.5 µM) was the most active PET inhibitor. The structure-activity relationships are discussed.
- 650 _2
- $a ampicilin $x farmakologie $7 D000667
- 650 _2
- $a anilidy $x chemická syntéza $x farmakologie $7 D000813
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x farmakologie $7 D000900
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a chloroplasty $x účinky léků $x fyziologie $7 D002736
- 650 _2
- $a transport elektronů $x účinky léků $x fyziologie $7 D004579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $x růst a vývoj $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a mikrobiální viabilita $x účinky léků $7 D050296
- 650 _2
- $a monocyty $x cytologie $x účinky léků $7 D009000
- 650 _2
- $a Mycobacterium avium subsp. paratuberculosis $x účinky léků $x růst a vývoj $7 D016927
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x růst a vývoj $7 D009169
- 650 _2
- $a naftaleny $x chemická syntéza $x farmakologie $7 D009281
- 650 _2
- $a fotosyntéza $x účinky léků $x fyziologie $7 D010788
- 650 _2
- $a rifampin $x farmakologie $7 D012293
- 650 _2
- $a Spinacia oleracea $x účinky léků $x fyziologie $7 D018724
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zadrazilova, Iveta $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. cizeka@vfu.cz. Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. cizeka@vfu.cz.
- 700 1_
- $a Nevin, Eoghan $u Department of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland. eoghan.nevin@mycit.ie.
- 700 1_
- $a Kauerova, Tereza $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. tereza.kauerova@gmail.com.
- 700 1_
- $a Pesko, Matus $u Department of Environmental Ecology, Faculty of Natural Sciences, Comenius University, Mlynska dolina Ch-2, 84215 Bratislava, Slovakia. matus.pesko@gmail.com.
- 700 1_
- $a Kos, Jiri $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. jurd@email.cz.
- 700 1_
- $a Oravec, Michal $u Global Change Research Centre AS CR, Belidla 986/4a, 60300 Brno, Czech Republic. oravec.m@czechglobe.cz.
- 700 1_
- $a Kollar, Peter $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. kollarp@vfu.cz.
- 700 1_
- $a Coffey, Aidan $u Department of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland. aidan.coffey@cit.ie.
- 700 1_
- $a O'Mahony, Jim $u Department of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland. jim.omahony@cit.ie.
- 700 1_
- $a Cizek, Alois $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. cizeka@vfu.cz.
- 700 1_
- $a Kralova, Katarina $u Institute of Chemistry, Faculty of Natural Sciences, Comenius University, Mlynska dolina Ch-2, 84215 Bratislava, Slovakia. kata.kralova@gmail.com.
- 700 1_
- $a Jampilek, Josef $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic. josef.jampilek@gmail.com.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 20, č. 6 (2015), s. 9767-87
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26023938 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160415122554 $b ABA008
- 999 __
- $a ok $b bmc $g 1113574 $s 934513
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 20 $c 6 $d 9767-87 $e 20150527 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20160408